Company / Free Cash Flow per Share
Prime Medicine, Inc. Free Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.27
FY2025
5-year range
-$4.56 / -$1.27
FY2021-FY2025
Trend
+28.8%
vs FY2024
Sector context
#114 of 192
Health Care
What the data says
At $-1.27, Prime Medicine, Inc.'s free cash flow per share ranks #114 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 3 consecutive years, from $-4.56 in FY2022 to $-1.27 in FY2025.
Based on SEC 10-K filings.
-1.27 in FY2025.
Improved from $-1.91 to $-1.27 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 192 in Health CareTop 59% of 192This company -$1.27 Sector average -$19.84
▼
+93.6% above sector average
Key checks
Key Insights
- Prime Medicine, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 28.8% year-over-year.
- Ranks #114 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -3.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.27 | +28.8% |
| FY2024 | -$1.79 | +6.6% |
| FY2023 | -$1.91 | +58.1% |
| FY2022 | -$4.56 | -54.9% |
| FY2021 | -$2.95 | -25.8% |
| FY2020 | -$2.34 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026